Literature DB >> 21228786

Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.

Yu Jin1, Lutgarde Thijs, Tom Richart, Yan Li, Eamon Dolan, Ji-Guang Wang, Athanase Protogerou, Eoin O'Brien, Jan A Staessen, Michel E Safar.   

Abstract

We investigated the effects of different antihypertensive drugs on the ambulatory arterial stiffness index (AASI), pulse pressure (PP), the arterio-ventricular coupling index (AVCI) and aortic pulse wave velocity (aPWV). After a 4-week placebo period, 94 and 107 patients with uncomplicated hypertension were randomly assigned to treatment with atenolol (AT) at dosage of 50 mg per day or perindopril/indapamide (PER/IND) at dosage of 2/0.6 mg per day for 1 year. From each patient's 24-h ambulatory blood pressure (BP) recording, we determined the 24-h systolic and diastolic BPs. We computed PP as the difference between 24-h systolic and diastolic BP, AASI as unity minus the regression slope of diastolic on systolic BP, and AVCI as (T/τ)/(1+2T/3τ), where T is the heart period in seconds and τ is the decay time of aortic BP during diastole. On AT compared with PER/IND, with adjustments applied for covariables, 24-h systolic BP (-9.5 vs. -13.7 mm Hg; P=0.009) and 24-h PP (-1.02 vs. -6.53 mm Hg; P<0.001) decreased less and AVCI lengthened more (+0.019 vs. -0.008; P<0.001). The changes in AASI (-0.001 vs. -0.014; P=0.44) and aPWV (-0.89 vs. -0.69 m s(-1); P=0.45) were similar in the two treatment groups. AASI and aPWV showed significant concordance (r=0.21, P=0.003) after adjustment for covariables. On administration of antihypertensive drugs with different hemodynamic profiles, AASI and aPWV behaved similarly. The similarity in the findings for aPWV and AASI support the use of AASI as an index reflecting the arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228786     DOI: 10.1038/hr.2010.256

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).

Authors:  Wei Tan; Krishna Madhavan; Kendall S Hunter; Daewon Park; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

2.  Treatment-induced changes in ambulatory arterial stiffness index: one-year prospective study and meta-analysis of evidence.

Authors:  Anastasios Kollias; Vayia Rarra; Nikos Karpettas; Leonidas Roussias; Eoin O'Brien; George S Stergiou
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

Review 3.  The current status of beta blockers' use in the management of hypertension.

Authors:  Shahid Akbar; Mohammad S Alorainy
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

4.  Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.

Authors:  J R M'Buyamba-Kabangu; B C Anisiuba; M B Ndiaye; D Lemogoum; L Jacobs; C K Ijoma; L Thijs; H J Boombhi; J Kaptue; P M Kolo; J B Mipinda; C E Osakwe; A Odili; B Ezeala-Adikaibe; S Kingue; B A Omotoso; S A Ba; I I Ulasi; J A Staessen
Journal:  J Hum Hypertens       Date:  2013-06-27       Impact factor: 3.012

5.  Heart rate variability on antihypertensive drugs in black patients living in sub-Saharan Africa.

Authors:  Chukwunomso E Osakwe; Lotte Jacobs; Benedict C Anisiuba; Mouhamado B Ndiaye; Daniel Lemogoum; Chinwuba K Ijoma; Marius M Kamdem; Lutgarde Thijs; Hilaire J Boombhi; Joseph Kaptue; Philip M Kolo; Jean B Mipinda; Augustine N Odili; Birinus Ezeala-Adikaibe; Samuel Kingue; Babatunde A Omotoso; Serigne A Ba; Ifeoma I Ulasi; Jean-Rene M'buyamba-Kabangu; Jan A Staessen
Journal:  Blood Press       Date:  2013-09-25       Impact factor: 2.835

6.  The Relationship Between Ambulatory Arterial Stiffness Index and Cardiovascular Outcomes in Women.

Authors:  Christopher J Boos; Lin Thiri-Toon; Christopher D Steadman; Sujata Khambekar; Andrew Jordan; John Paul Carpenter
Journal:  Cardiol Res       Date:  2021-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.